PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Reactions Weekly10.1007/s40278-022-17664-0202219111367-367Ruxolitinibhttps://link.springer.com/content/pdf/10.1007/s40278-022-17664-0.pdf, https://link.springer.com/article/10.1007/s40278-022-17664-0/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-17664-0.pdf
Reactions Weekly10.1007/s40278-022-17243-x202219101408-408Prednisone/rituximabhttps://link.springer.com/content/pdf/10.1007/s40278-022-17243-x.pdf, https://link.springer.com/article/10.1007/s40278-022-17243-x/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-17243-x.pdf
Reactions Weekly10.1007/s40278-015-1390-3201515731161-161Methylprednisolonehttp://link.springer.com/content/pdf/10.1007/s40278-015-1390-3.pdf, http://link.springer.com/article/10.1007/s40278-015-1390-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-1390-3
Reactions Weekly10.1007/s40278-014-8251-320141484111-11Ciclosporinhttp://link.springer.com/content/pdf/10.1007/s40278-014-8251-3.pdf, http://link.springer.com/article/10.1007/s40278-014-8251-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-014-8251-3
Reactions Weekly10.1007/s40278-016-13737-z201615841175-175Rituximabhttp://link.springer.com/content/pdf/10.1007/s40278-016-13737-z.pdf, http://link.springer.com/article/10.1007/s40278-016-13737-z/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-016-13737-z
Reactions Weekly10.1007/s40278-016-15391-8201615911147-147Prednisolonehttp://link.springer.com/content/pdf/10.1007/s40278-016-15391-8.pdf, http://link.springer.com/article/10.1007/s40278-016-15391-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-016-15391-8
Reactions Weekly10.1007/s40278-020-75920-3202017941124-124Immunosuppressantshttp://link.springer.com/content/pdf/10.1007/s40278-020-75920-3.pdf, http://link.springer.com/article/10.1007/s40278-020-75920-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-020-75920-3.pdf
Reactions Weekly10.1007/s40278-018-52726-320181723144-44Antineoplasticshttp://link.springer.com/content/pdf/10.1007/s40278-018-52726-3.pdf, http://link.springer.com/article/10.1007/s40278-018-52726-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-52726-3.pdf
Reactions Weekly10.1007/s40278-020-80720-5202018121241-241Prednisonehttps://link.springer.com/content/pdf/10.1007/s40278-020-80720-5.pdf, https://link.springer.com/article/10.1007/s40278-020-80720-5/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-020-80720-5.pdf
Reactions Weekly10.1007/s40278-018-42630-8201816921102-102Ciclosporinhttp://link.springer.com/content/pdf/10.1007/s40278-018-42630-8.pdf, http://link.springer.com/article/10.1007/s40278-018-42630-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-42630-8.pdf